Lipella Pharmaceuticals I...

2.51
-0.08 (-3.09%)
At close: Mar 31, 2025, 3:59 PM
2.35
-6.37%
After-hours: Mar 31, 2025, 05:42 PM EDT

Lipella Pharmaceuticals Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -0.00 -1.32 -55.4 -17.64 -492.64 -529.3
PEG Ratio -0.00 -0.00 -1.52 -0.01 -67.12 n/a
PS Ratio 0.01 13.61 781.01 127.35 34.04 47.12
PB Ratio 0.00 1.95 30.76 23.20 70.66 -276.62
P/FCF Ratio -0.00 -1.93 -78.54 -33.39 -1.15K -836.87
P/OCF Ratio -0.00 -1.94 -78.54 -33.39 -1.15K -836.87
OCF/S Ratio -7.37 -7.01 -9.94 -3.81 -0.03 -0.06
Debt / Equity Ratio 0.02 0.04 0.09 0.20 0.84 -0.85
Quick Ratio 3.47 8.90 5.02 5.31 3.37 0.72
Current Ratio 3.47 8.90 4.92 5.31 3.37 0.72
Asset Turnover 0.20 0.13 0.03 0.13 1.01 5.84
Interest Coverage n/a -437.5 -269.42 -280.34 -7.14 -6.41
Return on Equity (ROE) -2.61 -1.47 -0.56 -1.32 -0.14 0.52
Return on Assets (ROA) -1.88 -1.29 -0.44 -0.93 -0.07 -0.52
Return on Capital (ROIC) -2.65 -1.49 -0.54 -1.15 -0.08 1.15
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% -575.87% -1.28K% -461.71% -1.48% 1.71%
Net Profit Margin -935.25% -1.03K% -1.41K% -721.89% -6.91% -8.9%
Pretax Profit Margin -935.25% -1.03K% -1.41K% -719.3% -6.41% -8.9%
Operating Profit Margin -947.23% -1.06K% -1.41K% -738.71% -5.91% -7.74%
FCF Margin -736.59% -703.84% -994.35% -381.45% -2.97% -5.63%
EBITDA Margin -947.23% -1.02K% -1.41K% n/a -5.58% 0.05%